Skip to main content
NCBI home page
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1990 Apr;66(2):105–107. doi: 10.1136/sti.66.2.105

Sulphaphenazole, streptomycin and sulphaphenazole combination, trimethoprim, and erythromycin in the treatment of chancroid.

B Kumar 1, V K Sharma 1, V Bakaya 1
PMCID: PMC1194474  PMID: 2187791

Abstract

One hundred and thirty six patients with chancroid were treated with four different treatment regimens; (A) Sulphaphenazole 1 g 12 hourly by mouth x 10 days (B) Inj streptomycin 1 g intramuscularly daily with sulphaphenazole 1 g 12 hourly orally x 10 days; (C) trimethoprim 200 mg 12 hourly by mouth x 7-10 days, and (D) erythromycin 500 mg 6 hourly orally x 7-10 days. Cure rates of 9% with sulphaphenazole alone, 48% with streptomycin and sulphaphenazole combination, 93% with trimethoprim and 100% with erythromycin were obtained. Sulphaphenazole alone or in combination with streptomycin were thus inferior in the treatment of chancroid. There is need for modification of treatment regimens recommended for chancroid in the textbooks of dermatology and venereology. Trimethoprim can be recommended as first line of treatment for chancroid in developing countries like India where resistance to trimethoprim is uncommon and erythromycin is suggested as a second line of therapy because by that time syphilis can be easily ruled out.

Full text

PDF
105

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson B., Albritton W. L., Biddle J., Johnson S. R. Common beta-lactamase-specifying plasmid in Haemophilus ducreyi and Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1984 Feb;25(2):296–297. doi: 10.1128/aac.25.2.296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blackmore C. A., Limpakarnjanarat K., Rigau-Pérez J. G., Albritton W. L., Greenwood J. R. An outbreak of chancroid in Orange County, California: descriptive epidemiology and disease-control measures. J Infect Dis. 1985 May;151(5):840–844. doi: 10.1093/infdis/151.5.840. [DOI] [PubMed] [Google Scholar]
  3. Dylewski J., D'Costa L. J., Nsanze H., Ronald A. R. Single-dose therapy with trimethoprim-sulfametrole for chancroid in females. Sex Transm Dis. 1986 Jul-Sep;13(3):166–168. doi: 10.1097/00007435-198607000-00011. [DOI] [PubMed] [Google Scholar]
  4. Fast M. V., Nsanze H., D'Costa L. J., Karasira P., Maclean I. W., Piot P., Albritton W. L., Ronald A. R. Antimicrobial therapy of chancroid: an evaluation of five treatment regimens correlated with in vitro sensitivity. Sex Transm Dis. 1983 Jan-Mar;10(1):1–6. [PubMed] [Google Scholar]
  5. Jeyasingh P., Ramanaiah T. B., Fernandes S. D. Pattern of sexually transmitted disease in Madurai, India. Genitourin Med. 1985 Dec;61(6):399–403. doi: 10.1136/sti.61.6.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. McNicol P. J., Ronald A. R. The plasmids of Haemophilus ducreyi. J Antimicrob Chemother. 1984 Dec;14(6):561–564. [PubMed] [Google Scholar]
  7. Nayyar K. C., Stolz E., Michel M. F. Rising incidence of chancroid in Rotterdam. Epidemiological, clinical, diagnostic, and therapeutic aspects. Br J Vener Dis. 1979 Dec;55(6):439–441. doi: 10.1136/sti.55.6.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Plummer F. A., Nsanze H., D'Costa L. J., Karasira P., Maclean I. W., Ellison R. H., Ronald A. R. Single-dose therapy of chancroid with trimethoprim-sulfametrole. N Engl J Med. 1983 Jul 14;309(2):67–71. doi: 10.1056/NEJM198307143090202. [DOI] [PubMed] [Google Scholar]
  9. Rajan V. S., Sng E. H. Streptomycin-resistant Haemophilus ducreyi. Lancet. 1982 Nov 6;2(8306):1043–1043. doi: 10.1016/s0140-6736(82)90072-1. [DOI] [PubMed] [Google Scholar]
  10. Sanson-le Pors M. J., Casin I. M., Collatz E. Plasmid-mediated aminoglycoside phosphotransferases in Haemophilus ducreyi. Antimicrob Agents Chemother. 1985 Aug;28(2):315–319. doi: 10.1128/aac.28.2.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Schmid G. P. The treatment of chancroid. JAMA. 1986 Apr 4;255(13):1757–1762. [PubMed] [Google Scholar]
  12. Sturm A. W., Zanen H. C. Drug of choice for chancroid. Lancet. 1983 Jan 15;1(8316):125–125. doi: 10.1016/s0140-6736(83)91766-x. [DOI] [PubMed] [Google Scholar]
  13. Taylor D. N., Pitarangsi C., Echeverria P., Panikabutra K., Suvongse C. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand. J Infect Dis. 1985 Nov;152(5):1002–1006. doi: 10.1093/infdis/152.5.1002. [DOI] [PubMed] [Google Scholar]
  14. Zamzachin G., Gupta U., Singh O. P. A clinico-bacteriological study of "chancroidal" ulcers treated at AIIMS Hospital, New Delhi. Indian J Pathol Microbiol. 1986 Jul;29(3):277–283. [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES